However, these strains are less optimal for prospectively tracking the gradual transition from insulin sensitivity to insulin resistance, because IR arises early in life and progresses rapidly from a fixed genetic lesion with a minimal insulin-sensitive baseline and limited control over timing [10,11]. The gene discussed is INS; the disease is Insulin resistance.